GENT, Belgium--(BUSINESS WIRE)--Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc.

In one of the largest prevalence studies to date, researchers from the UK provide national, regional, and global genotype prevalence estimates for the hepatitis C virus. Findings indicate that ...

Patients with samples that were both HIV antibody and HCV RNA positive were retrospectively identified at the Alfred Hospital, Melbourne, from January 1996 onward. The study was approved by the ...

This news release is available in Japanese. A rapid, sensitive, and accurate method to detect drug resistant hepatitis C virus (HCV) mutants has been developed. Researchers at Hiroshima University ...

In previous articles of this series, we’ve discussed several aspects of the hepatitis C virus including the nature of the infection and its distribution both globally and in the United States. Most ...